170 related articles for article (PubMed ID: 9572886)
1. Synthesis and adrenergic activity of a new series of N-aryl dicyclopropyl ketone oxime ethers: SAR and stereochemical aspects.
Blanc M; Tamir A; Aubriot S; Michel MC; Bouzoubaa M; Leclerc G; Demenge P
J Med Chem; 1998 May; 41(10):1613-8. PubMed ID: 9572886
[TBL] [Abstract][Full Text] [Related]
2. Potent and selective human beta(3)-adrenergic receptor antagonists.
Candelore MR; Deng L; Tota L; Guan XM; Amend A; Liu Y; Newbold R; Cascieri MA; Weber AE
J Pharmacol Exp Ther; 1999 Aug; 290(2):649-55. PubMed ID: 10411574
[TBL] [Abstract][Full Text] [Related]
3. A pharmacodynamic study on clenbuterol-induced toxicity: beta1- and beta2-adrenoceptors involvement in guinea-pig tachycardia in an in vitro model.
Mazzanti G; Di Sotto A; Daniele C; Battinelli L; Brambilla G; Fiori M; Loizzo S; Loizzo A
Food Chem Toxicol; 2007 Sep; 45(9):1694-9. PubMed ID: 17449161
[TBL] [Abstract][Full Text] [Related]
4. Modulation of myocardial alpha 1- but not beta-adrenoceptors after 90-day tail-suspension.
Chen J; Zhang LF; Han C; Yu GS; Ma J
J Gravit Physiol; 1996 Apr; 3(1):57-62. PubMed ID: 11539308
[TBL] [Abstract][Full Text] [Related]
5. Interactions of a novel catecholamine, GP-2-128, with adrenoceptors.
Abou-Mohamed G; Caldwell RW; Carrier GO; Elmazar MM; Tuttle RR
J Cardiovasc Pharmacol; 1994 Mar; 23(3):492-500. PubMed ID: 7515996
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and alpha,beta-adrenergic blocking potency of 2,3-dihydro-1,4-benzodioxin derivatives. (I).
Khouili M; Guillaumet G; Coudert G; Pujol MD
Farmaco; 1996 Mar; 51(3):175-84. PubMed ID: 8688139
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and beta-adrenergic blocking activity of new aliphatic and alicyclic oxime ethers.
Bouzoubaa M; Leclerc G; Decker N; Schwartz J; Andermann G
J Med Chem; 1984 Oct; 27(10):1291-4. PubMed ID: 6148422
[TBL] [Abstract][Full Text] [Related]
8. Cycloalkanecarboxylic esters derived from lysergol, dihydrolysergol-I, and elymoclavine as partial agonists and antagonists at rat 5-HT2A receptors: pharmacological evidence that the indolo[4,3-fg]quinoline system of the ergolines is responsible for high 5-HT2A receptor affinity.
Pertz HH; Milhahn H; Eich E
J Med Chem; 1999 Feb; 42(4):659-68. PubMed ID: 10052973
[TBL] [Abstract][Full Text] [Related]
9. Partial agonist activity of bucindolol is dependent on the activation state of the human beta1-adrenergic receptor.
Maack C; Böhm M; Vlaskin L; Dabew E; Lorenz K; Schäfers HJ; Lohse MJ; Engelhardt S
Circulation; 2003 Jul; 108(3):348-53. PubMed ID: 12847069
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, docking study and β-adrenoceptor activity of some new oxime ether derivatives.
Ghabbour HA; El-Bendary ER; El-Ashmawy MB; El-Kerdawy MM
Molecules; 2014 Mar; 19(3):3417-35. PubMed ID: 24658567
[TBL] [Abstract][Full Text] [Related]
11. Testing conception of engagement of imidazoline receptors in imidazoline drugs effects on isolated rat heart atria.
Radwanska A; Dlugokecka J; Wasilewski R; Kaliszan R
J Physiol Pharmacol; 2009 Mar; 60(1):131-42. PubMed ID: 19439815
[TBL] [Abstract][Full Text] [Related]
12. beta-1 and beta-2, but not alpha-1 and alpha-2, adrenoceptor blockade delays rat cutaneous wound healing.
Romana-Souza B; Santos JS; Monte-Alto-Costa A
Wound Repair Regen; 2009; 17(2):230-9. PubMed ID: 19320892
[TBL] [Abstract][Full Text] [Related]
13. The effects of hydrocortisone on rat heart muscarinic and adrenergic alpha 1, beta 1 and beta 2 receptors, propranolol-resistant binding sites and on some subsequent steps in intracellular signalling.
Myslivecek J; Rícný J; Kolár F; Tucek S
Naunyn Schmiedebergs Arch Pharmacol; 2003 Nov; 368(5):366-76. PubMed ID: 14564448
[TBL] [Abstract][Full Text] [Related]
14. Enhanced G(i) signaling selectively negates beta2-adrenergic receptor (AR)--but not beta1-AR-mediated positive inotropic effect in myocytes from failing rat hearts.
Xiao RP; Zhang SJ; Chakir K; Avdonin P; Zhu W; Bond RA; Balke CW; Lakatta EG; Cheng H
Circulation; 2003 Sep; 108(13):1633-9. PubMed ID: 12975249
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and beta-adrenoreceptor blocking activity of [[3-(alkylamine)-2-hydroxypropyl]oximino]pyridines and O[3-(alkylamine)-2-hydroxypropyl]methylpyridine ketone oximes derivatives.
Manna F; Bolasco A; Bizzarri B; Lena R; Chimenti F; Filippelli A; Palla A; Fontana M
Farmaco; 1996; 51(8-9):579-87. PubMed ID: 8930111
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and alpha,beta-adrenergic blocking potency of 2,3-dihydro-1,4-benzodioxin derivatives. (II).
Khouili M; Guillaumet G; Coudert G; Pujol MD
Farmaco; 1996 Mar; 51(3):185-8. PubMed ID: 8688140
[TBL] [Abstract][Full Text] [Related]
17. Beta-adrenoreceptor blocking heterocyclic oximes and ethers.
Manna F; Chimenti F; Bolasco A; Lena R; Filippelli A; Falciani M; Fontana M
Farmaco; 1996 Nov; 51(11):699-706. PubMed ID: 9035376
[TBL] [Abstract][Full Text] [Related]
18. Temporal dynamics of inotropic, chronotropic, and metabolic responses during beta1- and beta2-AR stimulation in the isolated, perfused rat heart.
McConville P; Spencer RG; Lakatta EG
Am J Physiol Endocrinol Metab; 2005 Sep; 289(3):E412-8. PubMed ID: 15840637
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and structure-activity relationships of a new model of arylpiperazines. 4. 1-[omega-(4-Arylpiperazin-1-yl)alkyl]-3-(diphenylmethylene) - 2, 5-pyrrolidinediones and -3-(9H-fluoren-9-ylidene)-2, 5-pyrrolidinediones: study of the steric requirements of the terminal amide fragment on 5-HT1A affinity/selectivity.
López-Rodríguez ML; Morcillo MJ; Rovat TK; Fernández E; Vicente B; Sanz AM; Hernández M; Orensanz L
J Med Chem; 1999 Jan; 42(1):36-49. PubMed ID: 9888831
[TBL] [Abstract][Full Text] [Related]
20. Alpha and beta adrenergic effects of the stereoisomers of dobutamine.
Ruffolo RR; Spradlin TA; Pollock GD; Waddell JE; Murphy PJ
J Pharmacol Exp Ther; 1981 Nov; 219(2):447-52. PubMed ID: 6270308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
